PLSH — Panacea Life Sciences Holdings Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $3.58m
- $15.63m
- $2.38m
Annual balance sheet for Panacea Life Sciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.018 | 0.025 | 3.81 | 1.11 | 0.116 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.202 | 0 | 0.745 | 0.706 | 0.264 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2.43 | 0.051 | 9.1 | 6.38 | 4.66 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.65 | 0.02 | 12.4 | 10.9 | 10.3 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 9.8 | 0.071 | 23.8 | 19.5 | 18 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.19 | 4.9 | 10.1 | 15.1 | 19.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.58 | 3.09 | 16.7 | 21.6 | 26.3 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.22 | -3.02 | 7.1 | -2.14 | -8.29 |
| Total Liabilities & Shareholders' Equity | 9.8 | 0.071 | 23.8 | 19.5 | 18 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |